Agios Pharmaceuticals Forecast and Stock Analysis
Technical AGIO stock analysis for March 25, 2019.
Agios Pharmaceuticals gained 0.74% in the last trading day, rising from $62.29 to $62.75 The price has risen in 6 of the last 10 days , but is still down by -2.49% for this period. Volume fell in the last day by -83 443 shares, and in total, 268 863 shares bought and sold for approximately $16.87 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Monday, 25th Mar 2019) of the AGIO stock was $62.75. This is 0.74% more than the trading day before Friday, 22nd Mar 2019.
During day the stock fluctuated 3.20% from a day low at $61.00 to a day high of $62.95.
30 day high of the AGIO stock price was $68.94 and low was $59.51.
90 day high was $68.94 and low was $42.32.
52 week high for the Agios Pharmaceuticals - $99.82 and low - $41.63.
Agios Pharmaceuticals lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $62.61 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 36.54% during the next 3 months and, with 90% probability hold a price between $85.49 and $99.50 at the end of this period.
Only positive signals in the chart today. Agios Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $64.27. On a fall, the stock will find some support from the long-term average at approximately $61.01. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Friday March 22, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSI14 is 39 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $57.42 and $55.89.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agios Pharmaceuticals finds support just below today's level at $57.42. If this is broken, then the next support from accumulated volume will be at $55.89 and $51.00.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $1.95 (3.20%) between high and low. For the last week, the stock has had a daily average volatility of 4.09%.
Our recommended stoploss: $59.15 (-5.74%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 1 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.